Recruiting Pulmonary Embolism Studies in Heidelberg
A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18
This is a Phase 3, open-label, multicenter study to evaluate the safety, efficacy, PK, PD, and immunogenicity of cipaglucosidase alfa/miglustat treatment in ERT-experienced and ERT-naïve pediatric sub...
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
The aim of this study is to evaluate DCR-PHXC in participants with PH1 and severe renal impairment, with or without dialysis....
About Pulmonary Embolism Clinical Trials in Heidelberg
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Heidelberg, VICTORIA. These studies are seeking a combined 64 participants. Research is being sponsored by Amicus Therapeutics, Dicerna Pharmaceuticals, Inc., a Novo Nordisk company. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Heidelberg — FAQ
Are there pulmonary embolism clinical trials in Heidelberg?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Heidelberg, VICTORIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Heidelberg?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Heidelberg research site will contact you about next steps.
Are clinical trials in Heidelberg free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Heidelberg studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Heidelberg are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov